NIH Director Collins Says Religion Will Not Influence Agenda
Main Category: Stem Cell ResearchAlso Included In: Women's Health / Gynecology
Article Date: 19 Aug 2009 - 4:00 PDT
NIH Director Francis Collins on Monday said that his evangelical Christian faith will not undercut his decisions on medical science and research, the AP/Washington Post reports. In an interview with the Associated Press on his first day at work, Collins said, "The NIH director needs to focus on science," adding, "I have no religious agenda for the NIH." During the administration of President George W. Bush, the agency drew criticism for allowing religious ideology to influence policy, such as restrictions on federally funded embryonic stem cell research.
Collins, who is best known for his work in mapping the human genome, has a reputation for "finding common ground between belief in God and science," according to the AP/Post. President Obama nominated him for the post in July, and the Senate unanimously confirmed the nomination on Aug. 7. Collins worked at NIH for 15 years before leaving in 2008 to work on Obama's presidential campaign and found the BioLogos Foundation, which works to bridge gaps between faith and science. He said he resigned from BioLogos before starting his job as NIH director.
Collins on Monday outlined some of his objectives for NIH over the next few years. He said he plans to focus on personalized medicine, which uses a person's genes to customize treatment. For example, thousands of breast cancer survivors undergo unnecessary chemotherapy to rule out aggressive forms of the disease that they might not have, he said. According to Collins, new genetic tests have reduced unneeded chemo, saving nearly $100 million annually in health care costs. Embryonic stem cell research will be another focus area, he said. Under the Obama administration's new stem cell policy -- which Collins helped develop -- NIH will decide which of the 700 existing stem cells lines are eligible for federally funded research (Neergaard, AP/Washington Post, 8/18).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
Visit our stem cell research section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/161111.php>
APA
http://www.medicalnewstoday.com/releases/161111.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Director On Target
posted by John on 20 Aug 2009 at 8:33 amHappy to hear he won't let the Embryonic Stem Cell Religion (ESCR) influence his decisions but just let the scientific facts rule, i.e that the ESCR is run by false prophets who are lying are the effficacy of embryonic stem cells and that adult cells are where the help for people is.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





